Product NDC: | 0093-2060 |
Proprietary Name: | Fenofibrate |
Non Proprietary Name: | Fenofibrate |
Active Ingredient(s): | 145 mg/1 & nbsp; Fenofibrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-2060 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021656 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20041105 |
Package NDC: | 0093-2060-98 |
Package Description: | 90 TABLET in 1 BOTTLE (0093-2060-98) |
NDC Code | 0093-2060-98 |
Proprietary Name | Fenofibrate |
Package Description | 90 TABLET in 1 BOTTLE (0093-2060-98) |
Product NDC | 0093-2060 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fenofibrate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20041105 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | FENOFIBRATE |
Strength Number | 145 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |